English | Spanish
ecancer
Login Register
The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Conferences
  • About us
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+ -
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1510]
News [3613]
Articles [292]
Editorials [9]
Conferences [72]
elearning [23]
ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cancer
ASCO 2022: Novel agent increases PFS for patients with the most common type of advanced breast cance...
Ultrasound-guided microbubbles boost immunotherapy efficacy
Ultrasound-guided microbubbles boost immunotherapy efficacy
The paired perils of breast cancer and diabetes
The paired perils of breast cancer and diabetes
ECOG-ACRIN research highlights at ASCO 2022
ECOG-ACRIN research highlights at ASCO 2022
ASCO 2022: Study offers guidance for future trials of adjuvant therapy for patients with early HR+/HER2- breast cancer
ASCO 2022: Study offers guidance for future trials of adjuvant therapy for patients with early HR+/H...
ASCO 2022: Endocrine sensitivity test predicts survival benefit of dose-dense chemotherapy for patients with HR+ breast cancer, study finds
ASCO 2022: Endocrine sensitivity test predicts survival benefit of dose-dense chemotherapy for patie...
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer the...
Patient voices a good predictor of cancer treatment outcomes
Patient voices a good predictor of cancer treatment outcomes
Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals
Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals
Scientists discover a potential new marker to personalised therapy for breast cancer
Scientists discover a potential new marker to personalised therapy for breast cancer
<12345...362>

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Privacy Policy
  • Follow ecancer on Facebook
  • Follow ecancer on Twitter
  • Follow ecancer on Linkedin
  • Subscribe to the ecancer YouTube channel
© 2022 ecancer, all rights reserved
UK registered charity number: 1176307